The published human data supporting BPC-157 may not be strong, but, he argued, forbidding American companies from providing it would move it deeper into a market with no production or sourcing standards, no physician, no monitoring, and no record. That view was echoed by Jeffrey Egler, the chief medical officer at the telehealth company Noom
The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality
[26:13] We know iron is a good example of if youre low, you have a whole bunch of issues
That is the entire evidentiary basis for the first selective growth hormone secretagogue. The limits are equally specific: one species, acute dosing, a hormone panel not a safety profile, not chronic exposure, not human data